CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Ministério da Ciência, Tecnologia e Inovação (Brasil). Centro Nacional de Pesquisa em Energia e Materiais (CNPEM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Ciências Biológicas from Universidade Federal de São Paulo (2018). Has experience in Biochemistry, focusing on Mass Spectrometry (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Treatment of patients with oral squamous cell carcinoma (OSCC) represents a clinical challenge. Despite advances in therapeutic modalities, OSCC recurrence rates vary between 18% to 76% in patients that received the standard treatment of surgery, radiotherapy and/or chemotherapy. Moreover, OSCC patients demonstrates a low response to other therapeutic modalities, such as EGFR monotherapy …
Cystatin B (CSTB) has emerged as an important mediator of carcinogenesis, as well as angiogenesis and tumor growth. In our previous study (Carnielli et al., 2018), we have demonstrated that low level of CSTB, in front of tumor region, is correlated to poor prognostic in patients with oral cancer squamous cells carcinoma (OSCC). Additionally, we found out CSTB levels are correlated to loca…
The order of spiders (Araneae) is one of the most diversified in number of species and also one of the most successful group of venomous animals on Earth. One factor that contribute to the success of spiders is the production of a highly toxic venom from their glands, used to subdue prey and as a protection against predators. The composition of spider venoms is complex, but it is known th…
Oral squamous cell carcinoma (OSCC) is a prevalent type of oral cancer, comprising 90% of all oral malignancies worldwide. The five-year survival rate of patients diagnosed at advanced stages of the disease (Stages III or IV) is approximately 20%, making clear that the discovery of diagnostic and prognostic markers is essential to improve OSCC patients' outcomes, as early detection and tr…
| 3 / 3 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 4 / 4 | All Scholarships |
| Associated processes | |